These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 22358872)
21. The plasminogen activator inhibitor system in bone cell function. Allan EH; Martin TJ Clin Orthop Relat Res; 1995 Apr; (313):54-63. PubMed ID: 7641498 [TBL] [Abstract][Full Text] [Related]
22. Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation. Koli K; Keski-Oja J J Investig Dermatol Symp Proc; 1996 Apr; 1(1):33-8. PubMed ID: 9627689 [TBL] [Abstract][Full Text] [Related]
23. Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. Chen PK; Chang BI; Kuo CH; Chen PS; Cho CF; Chang CF; Shi GY; Wu HL FASEB J; 2013 Nov; 27(11):4520-31. PubMed ID: 23943648 [TBL] [Abstract][Full Text] [Related]
24. Human airway trypsin-like protease, a serine protease involved in respiratory diseases. Menou A; Duitman J; Flajolet P; Sallenave JM; Mailleux AA; Crestani B Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L657-L668. PubMed ID: 28235951 [TBL] [Abstract][Full Text] [Related]
25. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230 [TBL] [Abstract][Full Text] [Related]
26. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801 [TBL] [Abstract][Full Text] [Related]
28. [Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth]. Cosić SJ; Kovac Z Lijec Vjesn; 2011; 133(1-2):56-63. PubMed ID: 21644280 [TBL] [Abstract][Full Text] [Related]
29. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment. Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732 [TBL] [Abstract][Full Text] [Related]
30. Desmoplastic reaction influences pancreatic cancer growth behavior. Hartel M; Di Mola FF; Gardini A; Zimmermann A; Di Sebastiano P; Guweidhi A; Innocenti P; Giese T; Giese N; Büchler MW; Friess H World J Surg; 2004 Aug; 28(8):818-25. PubMed ID: 15457365 [TBL] [Abstract][Full Text] [Related]
31. Three-dimensional Mammary Epithelial Cell Morphogenesis Model for Analysis of TGFß Signaling. Rashidian J; Luo K Methods Mol Biol; 2016; 1344():121-35. PubMed ID: 26520121 [TBL] [Abstract][Full Text] [Related]
32. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells. Leksa V; Schiller HB; Stockinger H Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541 [TBL] [Abstract][Full Text] [Related]
33. Patients with idiopathic recurrent miscarriage have abnormally high TGFß+ blood NK, NKT and T cells in the presence of abnormally low TGFß plasma levels. Zhu L; Aly M; Kuon RJ; Toth B; Wang H; Karakizlis H; Weimer R; Morath C; Ibrahim E; Ekpoom N; Opelz G; Daniel V BMC Immunol; 2019 Mar; 20(1):10. PubMed ID: 30832584 [TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. Laiho M; Saksela O; Keski-Oja J J Biol Chem; 1987 Dec; 262(36):17467-74. PubMed ID: 3121597 [TBL] [Abstract][Full Text] [Related]
35. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Biliran H; Sheng S Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384 [TBL] [Abstract][Full Text] [Related]
36. Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin. Yamamoto K; Miyazaki K; Higashi S FEBS J; 2014 Aug; 281(15):3346-56. PubMed ID: 24903600 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
38. Nodal signaling in vertebrate development. Schier AF Annu Rev Cell Dev Biol; 2003; 19():589-621. PubMed ID: 14570583 [TBL] [Abstract][Full Text] [Related]
39. Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Tseng ZH; Vittinghoff E; Musone SL; Lin F; Whiteman D; Pawlikowska L; Kwok PY; Olgin JE; Aouizerat BE Heart Rhythm; 2009 Dec; 6(12):1745-50. PubMed ID: 19959123 [TBL] [Abstract][Full Text] [Related]
40. Proteinases and their inhibitors in cells and tissues. Rappay G Prog Histochem Cytochem; 1989; 18(4):1-61. PubMed ID: 2657864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]